Viewing Study NCT00218205


Ignite Creation Date: 2025-12-25 @ 3:08 AM
Ignite Modification Date: 2026-03-03 @ 12:31 AM
Study NCT ID: NCT00218205
Status: UNKNOWN
Last Update Posted: 2005-09-22
First Post: 2005-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer
Sponsor: Department of Veterans Affairs, New Jersey
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Epirubicin View
None Estramustine Phosphate View
None Celecoxib View
None Hormone Refractory Prostate Cancer View